MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-504-3p Has Tumor-Suppressing Activity and Decreases IFITM1 Expression in Non-Small Cell Lung Cancer Cells
Authors
Keywords
-
Journal
Genetic Testing and Molecular Biomarkers
Volume 26, Issue 7-8, Pages 351-359
Publisher
Mary Ann Liebert Inc
Online
2022-08-27
DOI
10.1089/gtmb.2021.0158
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lung Cancer 2020
- (2020) Brett C. Bade et al. CLINICS IN CHEST MEDICINE
- Deciphering the Roles of IFITM1 in Tumors
- (2020) Renba Liang et al. Molecular Diagnosis & Therapy
- Interferon-Induced Transmembrane Protein 1 (IFITM1) Promotes Distant Metastasis of Small Cell Lung Cancer
- (2020) Shuichi Sakamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Opposing activities of IFITM proteins in SARS‐CoV‐2 infection
- (2020) Guoli Shi et al. EMBO JOURNAL
- Rapid interferon independent expression of IFITM3 following T cell activation protects cells from influenza virus infection
- (2019) James G. Bedford et al. PLoS One
- MicroRNA‑504 targets AEG‑1 and inhibits cell proliferation and invasion in retinoblastoma
- (2019) Lina Wang et al. Molecular Medicine Reports
- Inhibiting of Proliferation, Migration, and Invasion in Lung Cancer Induced by Silencing Interferon-Induced Transmembrane Protein 1 (IFITM1)
- (2019) Jun Yan et al. Biomed Research International
- Cancer Progress and Priorities: Lung Cancer
- (2019) Matthew B. Schabath et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The IFITM protein family in adaptive immunity
- (2019) Diana C. Yánez et al. IMMUNOLOGY
- Deciphering miRNAs’ Action through miRNA Editing
- (2019) Marta Correia de Sousa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-504 inhibits cell proliferation and invasion by targeting LOXL2 in non small cell lung cancer
- (2018) Ming-fan Ye et al. BIOMEDICINE & PHARMACOTHERAPY
- MiRNA-based Therapeutics for Lung Cancer
- (2018) Miaowei Wu et al. CURRENT PHARMACEUTICAL DESIGN
- Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies
- (2018) Xiaohong Du et al. CURRENT PHARMACEUTICAL DESIGN
- Upregulation of PITX2 Promotes Letrozole Resistance via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells
- (2018) Ying-ying Xu et al. Cancer Research and Treatment
- MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling
- (2018) Hui Quan et al. BIOMEDICINE & PHARMACOTHERAPY
- MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance
- (2018) Mohammad Askandar Iqbal et al. MOLECULAR ASPECTS OF MEDICINE
- Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer
- (2018) Ying‐Gui Yang et al. INTERNATIONAL JOURNAL OF CANCER
- DDR2 and IFITM1 Are Prognostic Markers in Gallbladder Squamous Cell/Adenosquamous Carcinomas and Adenocarcinomas
- (2017) Daiqiang Li et al. PATHOLOGY & ONCOLOGY RESEARCH
- Reduced miR-105-1 levels are associated with poor survival of patients with non‑small cell lung cancer
- (2017) Gaixia Lu et al. Oncology Letters
- A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma
- (2016) Run Cui et al. CANCER LETTERS
- miR-127 promotes EMT and stem-like traits in lung cancer through a feed-forward regulatory loop
- (2016) L Shi et al. ONCOGENE
- Interferon-induced transmembrane protein 1 (IFITM1) is required for the progression of colorectal cancer
- (2016) Ita Novita Sari et al. Oncotarget
- IFITM1 promotes the metastasis of human colorectal cancer via CAV-1
- (2015) Fang Yu et al. CANCER LETTERS
- Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
- (2015) Ryo Yamashita et al. Cancer Medicine
- Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
- (2014) Yusuf Tutar CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma
- (2014) NAOKO KIKKAWA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- Enhanced survival of lung tissue-resident memory CD8+ T cells during infection with influenza virus due to selective expression of IFITM3
- (2013) Linda M Wakim et al. NATURE IMMUNOLOGY
- Overexpression of IFITM1 Has Clinicopathologic Effects on Gastric Cancer and Is Regulated by an Epigenetic Mechanism
- (2012) Jieun Lee et al. AMERICAN JOURNAL OF PATHOLOGY
- Identification of genes involved in radioresistance of nasopharyngeal carcinoma by integrating gene ontology and protein-protein interaction networks
- (2011) Xiao-Dong Zhu INTERNATIONAL JOURNAL OF ONCOLOGY
- Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice
- (2010) Nobutaka Hanagata et al. JOURNAL OF BONE AND MINERAL METABOLISM
- The widespread regulation of microRNA biogenesis, function and decay
- (2010) Jacek Krol et al. NATURE REVIEWS GENETICS
- The angiogenic switch in carcinogenesis
- (2009) Vanessa Baeriswyl et al. SEMINARS IN CANCER BIOLOGY
- MicroRNAs in Cancer
- (2008) Yong Sun Lee et al. Annual Review of Pathology-Mechanisms of Disease
- IFN-Induced Transmembrane Protein 1 Promotes Invasion at Early Stage of Head and Neck Cancer Progression
- (2008) H. Hatano et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search